{"id":"W2808310542","doi":"10.1136/annrheumdis-2018-eular.2638","title":"AB0415 Disease flares among early rheumatoid arthritis patients treated with continued methotrexate either alone or in combination with adalimumab","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Pfizer Japan; Ono Pharmaceutical; AbbVie Canada; Amgen; Astellas Foundation for Research on Metabolic Disorders; Teijin Pharma; Novo Nordisk; GlaxoSmithKline; Pfizer; Chugai Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Adalimumab; Methotrexate; Rheumatoid arthritis; Placebo; Internal medicine; Flare; Surgery; Pathology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004933197,0.0003331879,0.00078767,0.0005542796,0.0004370621,0.0007079375,0.0002318181,0.0005393105,0.002661501],"category_scores_gemma":[0.001412289,0.0002200239,0.0007569668,0.0004742043,0.0001855413,0.0005034176,0.0003232093,0.000638641,0.0002994404],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003592334,"about_ca_system_score_gemma":0.000311401,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002222752,"about_ca_topic_score_gemma":0.003880937,"domain_scores_codex":[0.9994461,0.0001423124,0.00006863859,0.00009097646,0.00009630028,0.000155669],"domain_scores_gemma":[0.9991168,0.0002480367,0.0003010285,0.00002645626,0.00006180107,0.0002458644],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009360236,0.0005742059,0.9613487,0.0000940956,0.0004376332,0.0009571153,0.0001568254,0.0001246544,0.002244017,0.00004578416,0.0005031623,0.02415359],"study_design_scores_gemma":[0.0001760415,0.00131537,0.9965148,0.00002041375,0.0002229492,0.0009741882,0.0001089087,0.000164779,0.00009992821,0.00002688949,0.0003675191,0.000008156598],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978197,0.0009503728,0.00002994872,0.00005476434,0.00001587933,0.000008966794,0.0001026811,0.000004642644,0.001013055],"genre_scores_gemma":[0.9993293,0.0001593902,0.00002778776,0.00006453151,0.00002745873,0.000005870863,0.0001478749,0.000001234158,0.0002366234],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002661501,"threshold_uncertainty_score":0.008903563,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02358805665698232,"score_gpt":0.2935004729738323,"score_spread":0.26991241631685,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}